BMS Financial Advisors’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
Other funds holding NVO
F
BMS Financial Advisors's NVO Position: Q2 2023 in Review
BMS Financial Advisors reduced its Novo Nordisk (NVO) stake by 26% in Q2 2023, selling an estimated $233K and leaving 8,136 shares worth $658K. The position accounts for 0.43% of the portfolio, ranked #35.
BMS Financial Advisors first reported a position in NVO in Q2 2022 and has held it in 5 quarters since. The position peaked at $874K in Q1 2023. 1,197 funds tracked by Wall St. Rank hold NVO as of Q2 2023.
- BMS Financial Advisors held 8,136 shares of Novo Nordisk worth $658K as of Q2 2023.
- BMS Financial Advisors sold 2,852 Novo Nordisk shares in Q2 2023, an estimated $233K.
- Novo Nordisk made up 0.43% of BMS Financial Advisors's portfolio in Q2 2023, its #35 holding.
- BMS Financial Advisors first reported a position in Novo Nordisk in Q2 2022 and has held it in 5 quarters since.
- BMS Financial Advisors's Novo Nordisk position peaked at $874K in Q1 2023.
- 1,197 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2023.
Based on BMS Financial Advisors's 13F filing for Q2 2023, filed 31 Jul 2023.